Device
Trigen Intertan
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Completion Rate
0%(0/1)
Active Trials
0(0%)
Terminated
1(33%)
Phase Distribution
Ph not_applicable
2
67%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 2 finished
Non-Completion Rate
100.0%
2 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Terminated(2)
Detailed Status
Not yet recruiting1
Withdrawn1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
0.0%
Most Advanced
N/A
Trials by Phase
N/A2 (100.0%)
Trials by Status
not_yet_recruiting133%
withdrawn133%
terminated133%
Recent Activity
0 active trials
Showing 3 of 3
not_yet_recruitingnot_applicable
InterTAN: Integrated Dual Screw Design Improve Biomechanics/Function Following Fixation Surgery
NCT06024304
withdrawn
A Study to Evaluate the Safety and Effectiveness of TRIGEN™ INTERTAN™ (10S Models)
NCT04865146
terminatednot_applicable
Trigen InterTAN vs Sliding Hip Screw RCT
NCT03065101
Clinical Trials (3)
Showing 3 of 3 trials
NCT06024304Not Applicable
InterTAN: Integrated Dual Screw Design Improve Biomechanics/Function Following Fixation Surgery
NCT04865146
A Study to Evaluate the Safety and Effectiveness of TRIGEN™ INTERTAN™ (10S Models)
NCT03065101Not Applicable
Trigen InterTAN vs Sliding Hip Screw RCT
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3